InsidersTradesSigma
Track the Medexus Pharmaceuticals Inc. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are listed on CA CA, under the supervision of SEDI. Market capitalisation: €158.3m. The latest transaction was reported on 6 July 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: Medexus Pharmaceuticals Inc.. The full history is free.
Medexus Pharmaceuticals Inc. has reported a total of 85 insider trading declarations in the last 90 days, all of which are buy transactions amounting to €895,083. The most recent declarations include multiple buy transactions on June 2, 2026, and July 6, 2026, all categorized under redemption, retraction, cancellation, or repurchase. The largest single transaction reported was €49,034.41 on June 2, 2026. Other notable transactions include amounts of €28,910.59, €28,284.10, and several others ranging from €25,337.47 to €25,542.68, all occurring on the same dates. No sell transactions were reported during this period.
Auto-generated summary, refreshed daily.Updated 2d ago
86
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Medexus Pharmaceuticals Inc. Strong Buy (bullish), based on 5 analysts. Average price target: CA$6.81.
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,630 of 27,969 companies
40.9
score / 100
Value39
Quality43
FCF yld2.3%
Earn yld-1.5%
EV/EBITDA14.3x
ROE-4.7%
Gross mgn55%
Net mgn-2.4%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
Declarations86 total
9,800 sharesCommon SharesTSXSEDI:4746209
9,800 shares@ CA$4.6830.028% mcap3.2% of flowCommon SharesTSXSEDI:4746208
9,500 sharesCommon SharesTSXSEDI:4746207
9,500 shares@ CA$4.39360.026% mcap2.9% of flowCommon SharesTSXSEDI:4746206
8,700 sharesCommon SharesTSXSEDI:4746205
8,700 shares@ CA$4.09290.022% mcap2.5% of flowCommon SharesTSXSEDI:4746204
10,000 sharesCommon SharesTSXSEDI:4746203
10,000 shares@ CA$4.07910.025% mcap3.1% of flowCommon SharesTSXSEDI:4746202
10,000 sharesCommon SharesTSXSEDI:4746201
10,000 shares@ CA$4.09660.025% mcap3.1% of flowCommon SharesTSXSEDI:4746200
6,300 sharesCommon SharesTSXSEDI:4746199
6,300 shares@ CA$4.04020.016% mcap1.9% of flowCommon SharesTSXSEDI:4746197
6,300 sharesCommon SharesTSXSEDI:4746196
6,300 shares@ CA$4.10540.016% mcap1.9% of flowCommon SharesTSXSEDI:4746195
10,000 sharesCommon SharesTSXSEDI:4746193
10,000 shares@ CA$4.20550.026% mcap3.2% of flowCommon SharesTSXSEDI:4746192
10,000 sharesCommon SharesTSXSEDI:4746189
10,000 shares@ CA$4.06950.025% mcap3.1% of flowCommon SharesTSXSEDI:4746188
2,800 sharesCommon SharesTSXSEDI:4746187
2,800 shares@ CA$4.09540.0070% mcap0.9% of flowCommon SharesTSXSEDI:4746186
4,500 sharesCommon SharesTSXSEDI:4746184
4,500 shares@ CA$4.07420.011% mcap1.4% of flowCommon SharesTSXSEDI:4746183
3,400 sharesCommon SharesTSXSEDI:4746182
3,400 shares@ CA$4.06350.0085% mcap1.0% of flowCommon SharesTSXSEDI:4746181
700 sharesCommon SharesTSXSEDI:4746179
25 of 86 declarations
About Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of therapeutic products. It is listed on the Toronto Stock Exchange under the symbol MDX.